Arylsulfonamidobenzylic compounds

Details for Australian Patent Application No. 2003210811 (hide)

Owner Amgen Inc.

Inventors Kayser, Frank; Piper, Derek E; Jiao, Xian Yun; Shiau, Andrew K; McKendry, Sharon

Agent Spruson & Ferguson

Pub. Number AU-B-2003210811

PCT Number PCT/US03/03149

PCT Pub. Number WO2003/063576

Priority 60/353,497 30.01.02 US

Filing date 29 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 14 August 2008

International Classifications

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/196 (2006.01)

A61K 31/216 (2006.01)

A61K 31/277 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4174 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/695 (2006.01) - Silicon compounds

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/04 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/353,497 30.01.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003210811

19 April 2007 Assignment before Grant

  Tularik Inc. The application has been assigned to Amgen Inc.

14 August 2008 Application Accepted

  Published as AU-B-2003210811

11 December 2008 Standard Patent Sealed

25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003210812-STABLE PHARMACEUTICAL COMPOSITION USEFUL FOR TREATING GASTROINTESTINAL DISORDERS

2003210810-OPEN MOLD MANUFACTURING PROCESS WITH CENTRALIZED APPLICATION STATION